NCT03620357View on ClinicalTrials.gov

Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 5, 2018

Primary Completion Date

May 27, 2020

Study Completion Date

November 4, 2020

Conditions
Diabetes Mellitus, Type 2
Interventions
DEVICE

CGM

CGM Group: Dexcom G6 CGM

DEVICE

SMBG

SMBG Group: Blood Glucose Meter

Trial Locations (10)

21204

MODEL Clinical Research (Towson), Baltimore

30318

Atlanta Diabetes Associates, Atlanta

68114

Diabetes & Endocrine Associates, PC, Omaha

78229

Diabetes and Glandular Disease Clinic, San Antonio

89052

Las Vegas Endocrinology, Henderson

89113

The Docs, Las Vegas

89148

Palm Research Center, Las Vegas

92592

Temecula Valley Endocrinology, Temecula

92648

Diabetes/Lipid Management and Research Center, Huntington Beach

M4G 3E8

LMC Manna Research, Toronto

All Listed Sponsors
lead

DexCom, Inc.

INDUSTRY

NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) | Biotech Hunter | Biotech Hunter